VANECK PHARMACEUTICAL ETF
SCHEDULE OF INVESTMENTS
June 30, 2022 (unaudited)
Number of Shares | Value | |||||||
COMMON STOCKS: 99.7% | ||||||||
Denmark: 4.9% | ||||||||
Novo Nordisk A/S (ADR) | 258,530 | $ | 28,807,998 | |||||
France: 4.8% | ||||||||
Sanofi (ADR) | 566,931 | 28,363,558 | ||||||
Ireland: 0.3% | ||||||||
Amarin Corp. Plc (ADR) * † | 1,034,866 | 1,541,950 | ||||||
Israel: 3.7% | ||||||||
Teva Pharmaceutical Industries Ltd. (ADR) * | 2,861,816 | 21,520,856 | ||||||
Japan: 4.8% | ||||||||
Takeda Pharmaceutical Co. Ltd. (ADR) † | 1,989,772 | 27,936,399 | ||||||
Switzerland: 4.9% | ||||||||
Novartis AG (ADR) | 343,204 | 29,011,034 | ||||||
United Kingdom: 9.7% | ||||||||
AstraZeneca Plc (ADR) | 463,214 | 30,604,549 | ||||||
GSK Plc (ADR) † | 610,433 | 26,572,149 | ||||||
57,176,698 | ||||||||
United States: 66.6% | ||||||||
AbbVie, Inc. | 200,873 | 30,765,709 | ||||||
AmerisourceBergen Corp. | 184,276 | 26,071,368 | ||||||
Bausch Health Cos, Inc. * † | 762,281 | 6,372,669 | ||||||
Bristol-Myers Squibb Co. | 393,527 | 30,301,579 | ||||||
Catalent, Inc. * | 243,445 | 26,119,214 |
Number of Shares | Value | |||||||
United States (continued) | ||||||||
Elanco Animal Health, Inc. * | 749,824 | $ | 14,719,045 | |||||
Eli Lilly & Co. | 95,620 | 31,002,873 | ||||||
Jazz Pharmaceuticals Plc * | 136,876 | 21,354,025 | ||||||
Johnson & Johnson | 169,104 | 30,017,651 | ||||||
McKesson Corp. | 85,653 | 27,940,865 | ||||||
Merck & Co., Inc. | 335,040 | 30,545,597 | ||||||
Organon & Co. | 609,152 | 20,558,880 | ||||||
Patterson Companies, Inc. | 165,836 | 5,024,831 | ||||||
Perrigo Co. Plc | 248,279 | 10,072,679 | ||||||
Pfizer, Inc. | 560,676 | 29,396,243 | ||||||
Viatris, Inc. | 2,274,988 | 23,819,124 | ||||||
Zoetis, Inc. | 157,517 | 27,075,597 | ||||||
391,157,949 | ||||||||
Total Common Stocks (Cost: $608,886,674) | 585,516,442 | |||||||
SHORT-TERM INVESTMENT HELD AS COLLATERAL FOR SECURITIES ON LOAN: 0.3% (Cost: $1,658,664) | ||||||||
Money Market Fund: 0.3% | ||||||||
State Street Navigator Securities Lending Government Money Market Portfolio | 1,658,664 | 1,658,664 | ||||||
Total Investments: 100.0% (Cost: $610,545,338) | 587,175,106 | |||||||
Liabilities in excess of other assets: 0.0% | (250,412) | |||||||
NET ASSETS: 100.0% | $ | 586,924,695 |
Definitions:
ADR | American Depositary Receipt |
Footnotes:
† | Security fully or partially on loan. Total market value of securities on loan is $4,347,556. |
* | Non-income producing |
Summary of Investments by Sector Excluding Collateral for Securities Loaned | % of Investments | Value | ||||||
Biotechnology | 5.6 | % | $ | 32,307,659 | ||||
Health Care Distributors | 10.1 | 59,037,065 | ||||||
Pharmaceuticals | 84.3 | 494,171,718 | ||||||
100.0 | % | $ | 585,516,442 |
1 |